| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.7 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |